Japanese

KUMASHIRO Naoki

■Faculty	Department of Diabetology and Endocrinology
■Position	Professor

Researcher Profile & Settings

Research

Overview of research:

We promote basic and clinical research to help diabetic patients lead a life equivalent to a non-diabetic person. We will advocate for early therapeutic intervention to prevent cardiovascular and microvascular complications. In consideration of an aging society, we will also be aware of measures to combat complications of sarcopenia and other geriatric syndromes. We also aim to preserve and improve patients' quality of life. As for research methods, continuing basic research using conventional mice and cells is essential, and we will actively conduct human studies to build evidence useful in daily clinical practice. In this process, we will apply various advanced clinical examination techniques and make full use of data analysis using digital devices and artificial intelligence.

Research Activities

Published Papers

Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: a sub-analysis of the DIVERSITY-CVR study, (Kota Takuma),(Ayako Fuchigami), Fumika Shigiyama, Naoki Kumashiro, Takahisa Hirose, Diabetes, Obesity and Metabolism, 25:2131-2141, Aug. 2023
DOI:10.1111/dom.15089
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with nonalcoholic fatty liver disease: a prospective randomized study, (Shigenori Hiruma), Fumika Shigiyama, Naoki Kumashiro, Diabetes, Obesity and Metabolism, 25:1576-1588, Jun. 2023
DOI:10.1111/dom.15006

Note: Performance information for the past 1-2 years may be revised at a later date due to inspections conducted by the committee from July to September every year.